• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing

Momenta Pharmaceuticals Could Finally Make a Big Upside Breakout

Let's review the charts and indicators.
By BRUCE KAMICH
May 13, 2020 | 11:54 AM EDT
Stocks quotes in this article: XBI, MNTA

Many biotech companies have been surging and the SPDR Biotech ETF ( XBI) has broken out over the highs of 2018-2020. Let's check out the charts of Momenta Pharmaceuticals ( MNTA) , a biotechnology company with a scientific platform focused on discovering and developing novel therapeutics to treat rare, immune-mediated diseases.  
 
In this daily bar chart of MNTA, below, we can see that prices have made new highs for the move up. MNTA is trading above the rising 50-day moving average line and above the rising 200-day moving average line.
 
The daily On-Balance-Volume (OBV) line has moved sideways so far this year but it remains close to making a new high. A new high in the OBV line would help confirm the price gains.
 
The Moving Average Convergence Divergence (MACD) oscillator is above the zero line but "waffling" a little bit - we could see a new buy signal or a take profits signal depending on the price action ahead.   
 
 
In this weekly bar chart of MNTA, we can see the action of the past three years. We see a positive looking picture with prices in an uptrend and above the rising 40-week moving average line.
 
The weekly OBV line is bullish and tells us that buyers of MNTA have been more aggressive since late 2018. The MACD oscillator is bullish and poised to turn higher. 
  
 
 
In this long-term monthly bar chart of MNTA, below, we can see that prices have been in a long-term sideways trend. Prices are up at the upper end of this big pattern and poised for a breakout to the topside. 
 
 
 
In this weekly close only Point and Figure chart of MNTA, below, we can see a potential upside price target in the $61 area.  
 
Bottom line strategy: The monthly chart of MNTA, above, is one of the longest sideways patterns I can remember seeing in a while. The shorter charts suggest that prices now have the power or ability for an upside breakout. Aggressive traders could consider going long MNTA at current levels and risking a close below $28. The $60 area is our longer-term price target. 
Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Employees of TheStreet are prohibited from trading individual securities.

TAGS: ETFs | Investing | Stocks | Technical Analysis | Trading | Biotechnology | Pharmaceuticals

More from Investing

Specific Stocks Appear Solid but Upward Momentum Can't Yet Be Trusted

James "Rev Shark" DePorre
May 19, 2022 4:29 PM EDT

I remain convinced that we can't begin to talk about a bottom in the indexes until the S&P 500 is in a technical bear market.

Is This the Time to Buy Costco?

Bruce Kamich
May 19, 2022 3:05 PM EDT

Buy a falling knife? No, but this one's intriguing.

Stay on Track While Interpreting the Dow Theory and CSX Corp.

Bruce Kamich
May 19, 2022 2:26 PM EDT

Some investors may be asking whether we're seeing another 'nail in the coffin' of the secular bull market as several transport names get downgraded. Let's not ... go off the rails.

TJX Cos. Is Ignoring the Market's Downdraft

Bruce Kamich
May 19, 2022 1:25 PM EDT

Does this strength have staying power?

These ETFs Will Meet You in the After-Hours Club

Mark Abssy
May 19, 2022 12:30 PM EDT

Let's check three funds that are set to buy the close and sell the open.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 01:44 PM EDT STEPHEN GUILFOYLE

    Stocks Under $10 Portfolio

    We're making a series of trades here.
  • 03:07 PM EDT PAUL PRICE

    Why Is Walmart Down Big Today?

    Besides its poor earnings report Walmart was way...
  • 07:14 PM EDT PAUL PRICE

    A New, Very Scary Movie

  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2022 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login